Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative bre
7 hours ago
- #Biomarkers
- #Triple-negative breast cancer
- #Inflammation
- Study integrates Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer.
- Research focuses on biomarker-based stratification, immune microenvironment, and systemic inflammation in triple-negative breast cancer.
- Retrospective study design with waived informed consent, approved by Non-Interventional Clinical Research Ethics Committee of Pamukkale University.
- Data not publicly available due to confidentiality; access possible upon request and institutional approval.
- Authors declare no competing interests.
- References include studies on prognostic significance, therapeutic vulnerabilities, and neoadjuvant chemotherapy efficacy in breast cancer.